Close Menu

NEW YORK (GenomeWeb) – With their potential to enable easier patient sampling and significantly lower assay costs, dried blood spots are an area of growing interest among clinical proteomic researchers and companies.

Some recent studies indicate, however, that technical hurdles still stand in the way of clinical implementation of this sample collection technique.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.